VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
GRDN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
GRDNGuardian Pharmacy Services, Inc.
$46.94$3.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGRDNQuarterly Financials

Guardian Pharmacy Services, Inc. (GRDN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Guardian Pharmacy Services, Inc. (GRDN) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

GRDN Income Statement

Quarterly statement

GRDN Income Statement

Guardian Pharmacy Services, Inc. (GRDN) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q2'23Q1'23Q4'22Q3'22Q4'21Q3'21Q1'21Q4'20
Sales/Revenue371.07M351.77M336.6M397.62M377.43M344.33M329.31M338.57M314.39M300.04M275.41M281.07M253.44M248.95M236.89M236.89M209.89M203.59M181.31M188.54M
Revenue Growth %-1.68%2.16%2.21%17.44%20.05%14.76%19.57%20.46%-18.39%10.63%18.65%--12.87%16.36%11.32%--2.22%3.14%
Cost of Goods Sold285.85M271.72M260.29M312.11M302.71M276.19M264.96M271.46M253.51M238.75M220.31M226.49M203.12M197.73M188.12M188.12M167.95M162.02M146.43M151.51M
COGS % of Revenue77.03%77.25%77.33%78.5%80.2%80.21%80.46%80.18%80.64%79.57%79.99%80.58%80.14%79.43%79.41%79.41%80.02%79.58%80.76%80.36%
Gross Profit85.22M80.04M76.31M85.5M74.72M68.15M64.35M67.1M60.88M61.29M55.1M54.58M50.32M51.22M48.78M48.78M41.94M41.57M34.88M37.02M
Gross Margin %22.97%22.75%22.67%21.5%19.8%19.79%19.54%19.82%19.36%20.43%20.01%19.42%19.86%20.57%20.59%20.59%19.98%20.42%19.24%19.64%
Gross Profit Growth %14.06%17.46%18.59%27.42%22.74%11.19%16.78%22.95%-21.79%7.58%11.9%--16.3%17.34%13.28%--6.76%-2.11%
Operating Expenses60.16M59.4M58.63M48.91M57.89M55.57M51.34M50.35M165.49M44.28M47.17M39.05M25.03M44.76M32.71M32.71M43.21M25.77M32.49M24.44M
OpEx % of Revenue16.21%16.89%17.42%12.3%15.34%16.14%15.59%14.87%52.64%14.76%17.13%13.89%9.88%17.98%13.81%13.81%20.59%12.66%17.92%12.96%
Selling, General & Admin60.16M59.4M58.63M48.91M57.89M55.57M51.34M50.35M165.49M44.28M47.17M39.05M25.03M44.76M32.72M32.72M51.45M23.23M29.47M20.84M
SG&A % of Revenue16.21%16.89%17.42%12.3%15.34%16.14%15.59%14.87%52.64%14.76%17.13%13.89%9.88%17.98%13.81%13.81%24.51%11.41%16.25%11.05%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses00000000000000-12K-12K-1000K1000K1000K1000K
Operating Income25.06M20.64M17.68M36.6M16.83M12.58M13.01M16.75M-104.61M17M7.93M15.52M25.3M6.46M16.07M16.07M-1.27M15.79M2.39M12.58M
Operating Margin %6.75%5.87%5.25%9.2%4.46%3.65%3.95%4.95%-33.27%5.67%2.88%5.52%9.98%2.59%6.78%6.78%-0.61%7.76%1.32%6.67%
Operating Income Growth %48.95%64.1%35.91%118.42%116.08%-26.02%63.94%7.93%--32.77%22.86%-3.4%--1361.38%1.74%-110.13%-9.64%48.98%
EBITDA31M26.45M23.65M42.34M22.66M18.07M18.27M21.91M-99.62M21.88M12.68M20.24M29.72M10.91M20.31M20.31M2.85M18.5M6.66M16.94M
EBITDA Margin %8.35%7.52%7.03%10.65%6.01%5.25%5.55%6.47%-31.69%7.29%4.61%7.2%11.73%4.38%8.57%8.57%1.36%9.09%3.67%8.99%
EBITDA Growth %36.75%46.39%29.44%93.25%122.75%-17.41%44.06%8.25%--26.38%16.21%-0.33%--613.48%9.75%-83.2%-4.47%33.24%
D&A (Non-Cash Add-back)5.93M5.81M5.98M5.74M5.84M5.49M5.27M5.15M4.99M4.87M4.75M4.71M4.42M4.46M4.24M4.24M4.12M2.71M4.27M4.36M
EBIT26.15M29.95M18.45M31.26M16.79M12.76M13.28M16.64M-104.61M16.91M7.86M15.3M25.14M6.42M16.06M16.06M-1.35M15.79M2.42M12.42M
Net Interest Income-177K-154K-154K-163K-160K-172K-170K-421K-1.03M-1.07M-765K-739K-702K-702K-549K-549K-398K-405K-416K-443K
Interest Income00000000000000-549K-549K0000
Interest Expense177K154K154K163K160K172K170K421K1.03M1.07M765K739K702K702K00398K405K416K443K
Other Income/Expense914K9.15M618K-5.5M-196K7K101K-534K-1.03M-1.16M-838K-965K-853K-743K-671K-671K-470K-407K-390K-606K
Pretax Income25.98M29.79M18.29M31.1M16.63M12.59M13.11M16.22M-105.64M15.85M7.09M14.56M24.44M5.71M15.4M15.4M-1.74M15.39M2M11.97M
Pretax Margin %7%8.47%5.43%7.82%4.41%3.66%3.98%4.79%-33.6%5.28%2.58%5.18%9.64%2.3%6.5%6.5%-0.83%7.56%1.1%6.35%
Income Tax6.86M7.67M4.75M9.83M7.04M3.76M3.83M4.38M176K00000000000
Effective Tax Rate %26.4%25.75%25.96%31.62%42.32%29.87%29.25%27%-0.17%0%0%0%0%0%0%0%0%0%0%0%
Net Income18.68M21.87M13.29M20.92M9.82M9.03M9.45M11.94M-112.64M10.62M2.79M12.02M21.47M1.7M11.7M11.7M-4.92M12.26M-67K9.67M
Net Margin %5.03%6.22%3.95%5.26%2.6%2.62%2.87%3.53%-35.83%3.54%1.01%4.28%8.47%0.68%4.94%4.94%-2.34%6.02%-0.04%5.13%
Net Income Growth %90.26%142.21%40.72%75.19%108.72%-15%239.12%-0.62%--50.52%63.5%2.74%--338%-4.62%-150.82%-93.21%77.65%
Net Income (Continuing)19.12M22.12M13.54M21.27M9.59M8.83M9.27M11.84M-105.82M15.85M7.09M14.56M24.44M5.71M15.4M15.4M-1.74M15.39M2M11.97M
Discontinued Operations00000000000000000000
Minority Interest12.48M12.03M11.53M12.16M11.74M10.11M7.13M7.3M6.33M39.34M031.65M32.77M34.45M33.2M33.2M29.39M29.21M27.84M28.59M
EPS (Diluted)0.290.340.210.330.150.140.150.20-2.000.17-0.140.380.350.030.000.00-0.080.20-0.000.16
EPS Growth %93.33%142.86%40%65%107.5%-17.65%207.14%-47.37%--51.43%-600%---100%-100%-150.5%-93.21%78.77%
EPS (Basic)0.290.350.210.330.160.150.150.20-2.000.17-0.140.380.350.030.000.00-0.080.20-0.000.16
Diluted Shares Outstanding63.92M63.84M63.69M63.62M63.43M63.2M62.91M61.14M61.14M60.84M60.84M60.84M60.84M60.84M0060.84M60.84M60.84M60.84M
Basic Shares Outstanding63.34M63.33M63.32M63.32M62.12M62.05M62.04M61.14M61.14M60.84M60.84M60.84M60.84M60.84M0060.84M60.84M60.84M60.84M
Dividend Payout Ratio-------2.51%-156.36%255.92%83.21%73.24%361.85%20.06%20.06%---40.21%